In 2017, China’s western medicine products exported 35.456 billion U.S. dollars, an increase of 12.62%. Among them, the export of APIs was US$291.17 billion, which represented a year-on-year increase of 13.71%. The US, EU, India and other major markets increased by 23.84%, 9.79%, and 13.52%, respectively.
The environmental protection costs of raw material companies continued to rise, prompting supply side contraction, backward production capacity gradually withdrawing, the competitive landscape of high-quality enterprises ushering in a continuous improvement, and the international market share and bargaining power are gradually increasing. The concentration of export companies and the increase in export prices are two The main features.
In 2017, the average price of 25 bulk APIs rose 10.45 percent, which is the main reason for the growth of APIs exports.
Click on the image below to register for the exhibition!
